Frequency of Late Drug-Eluting Stent Thrombosis With Non-Cardiac Surgery

American Journal of Cardiology

Volumn 106, Issue 1, 2010, Pages 1-3

  Chia, Karin K M ^a,b   Park, John J ^b   Postle, James ^b   Cottrill, Andrew ^c   Ward, Michael R ^a,b  

^a ROYAL NORTH SHORE HOSPITAL   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c Health Contributions Fund   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL;

AGED; ANGIOCARDIOGRAPHY; ARTICLE; CONTROLLED STUDY; DRUG ELUTING STENT THROMBOSIS; FUNDING; HEART INFARCTION; HUMAN; IMPLANTATION; MAJOR CLINICAL STUDY; MEDICAL RECORD; PATIENT IDENTIFICATION; PERIOPERATIVE PERIOD; PRIORITY JOURNAL; QUESTIONNAIRE; STENT; STENT THROMBOSIS;

AGED; AGED, 80 AND OVER; CORONARY RESTENOSIS; CORONARY THROMBOSIS; DRUG-ELUTING STENTS; FEMALE; HUMANS; MALE; MIDDLE AGED; PLATELET AGGREGATION INHIBITORS; RISK FACTORS; SURGICAL PROCEDURES, ELECTIVE; TIME FACTORS; TREATMENT OUTCOME;

EID: 77953610454     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2010.02.006     Document Type: Article

References (8)

1. Kimura T., Morimoto T., Nakagawa Y., Tamura T., Kadota K., Yasumoto H., Nishikawa H., Hiasa Y., Muramatsu T., Meguro T., Inoue N., Honda H., Hayashi Y., Miyazaki S., Oshima S., Honda T., Shiode N., Namura M., Sone T., Nobuyoshi M., Kita T., and Mitsudo K. Antiplatelet therapy and stent thrombosis after sirolimus-eluting stent implantation. Circulation 119 (2009) 987-995
2. To A.C.Y., Armstrong G., Zeng I., and Webster M.W.I. Non-cardiac surgery and bleeding after percutaneous coronary intervention. Circ Cardiovasc Intervent 2 (2009) 213-221
3. Grines C.L., Bonow R.O., Casey Jr. D.E., Gardner T.J., Lockhart P.B., Moliterno D.J., O'Gara P., and Whitlow P. Prevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents: a science advisory from the American Heart Association, American College of Cardiology, Society for Cardiovascular Angiography and Interventions, American College of Surgeons, and American Dental Association, with representation from the American College of Physicians. Circulation 115 (2007) 813-818
4. Kim H.L., Park K.H., Kwak J.J., Kim Y.S., Sir J.J., Lee S.J., Lee H.Y., Chang H.J., Kang H.J., Cho Y.S., Chung W.Y., Chae I.H., Choi D.J., Kim H.S., Oh B.H., Park Y.B., and Koo B.K. Stent-related cardiac events after non-cardiac surgery: drug-eluting stent vs bare metal stent. Int J Cardiol 123 (2008) 353-354
5. Rhee S.J., Yun K.H., Chae J.K., Nam C.W., Jun D.H., and Jeong J.W. Drug-eluting stent thrombosis during perioperative period. Int Heart J 49 (2008) 135-142
6. Godet G., Le Manach Y., Lesache F., Perbet S., and Coriat P. Drug-eluting stent thrombosis in patients undergoing non-cardiac surgery: is it always a problem?. Br J Anaesth 100 (2008) 472-477
7. Brotman D.J., Bakhru M., Saber W., Aneja A., Bhatt D.L., Tillan-Martinez K., and Jaffer A.K. Discontinuation of antiplatelet therapy prior to low risk non-cardiac surgery in patients with drug-eluting stents: a retrospective cohort study. J Hosp Med 2 (2007) 378-384
8. Iakovou I., Schmidt T., Bonizzoni E., Lei G., Sangiorgi G.M., Stankovic G., Airoldi F., Chieffo A., Montorfano M., Carlino M., Michev I., Corvaja N., Briguori C., Gerckens U., Grube E., and Colombo A. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA 293 (2005) 2126-2130